Romedahl MedScience ApS: Financial statements 2025
CVR: 38540580
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Romedahl MedScience ApS (CVR 38540580) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK -8,552 compared with DKK -6,398 the year before. Equity in the 2025 report amounted to DKK 642. The solvency ratio was 2.2%.
- Profit/Loss
- DKK -8,552
- Equity
- DKK 642
- Total Assets
- DKK 29,538
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | -9K | 642 | 0 |
| 2024 | - | - | -6K | 9K | 1 |
| 2023 | - | - | -6K | 16K | 1 |
| 2022 | - | - | -5K | 22K | 1 |
| 2021 | - | - | -8K | 27K | 1 |
Official annual report
How creditworthy is Romedahl MedScience ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Romedahl MedScience ApS has published its annual report for 2024. The net result was DKK -6,398.
About Romedahl MedScience ApS
Romedahl MedScience ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Romedahl MedScience IVS. The management consists of Hanne Risager Romedahl. The company is owned by Hanne Risager Romedahl. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -8,552 compared with DKK -6,398 the year before. Equity in the 2025 report amounted to DKK 642.